Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.7B | 4.9B | 5.4B | 5.3B |
Cost of revenue | 3.0B | 3.2B | 3.5B | 3.4B |
Gross profit | 1.7B | 1.7B | 2.0B | 1.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 858.6M | 903.2M | 949.8M | 904M |
Other operating expenses | — | — | — | — |
Operating income | 818.9M | 807.6M | 1.0B | 1.0B |
Non operating interest income | ||||
Income | 3.3M | 11.5M | 15.3M | 5.4M |
Expense | 58.1M | 59.9M | 63M | 57.5M |
Other income expense | -11.2M | -8.6M | -9M | -6.8M |
Pretax income | 752.9M | 750.6M | 967.9M | 972.6M |
Tax provision | 134.9M | 135.3M | 181.1M | 205.8M |
Net income | 609.1M | 611.9M | 777.9M | 759.9M |
Basic EPS | 2.7 | 2.7 | 3.4 | 3.3 |
Diluted EPS | 2.7 | 2.7 | 3.4 | 3.3 |
Basic average shares | 223.2M | 224.5M | 225.8M | 226.6M |
Diluted average shares | 226.4M | 227.3M | 228M | 228.7M |
EBITDA | 912.1M | 911.4M | 1.1B | 1.1B |
Net income from continuing op. | 618M | 615.3M | 786.9M | 766.8M |
Minority interests | -4.2M | -7.6M | -5.9M | -4.6M |
Preferred stock dividends | — | — | — | — |